CS Diagnostics Corp. (CSDX)
0.0105
0.00 (0.00%)
USD |
OTCM |
Aug 25, 16:00
CS Diagnostics Profit Margin (Quarterly) : 35.61% for Dec. 31, 2025
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2025 | 35.61% |
| September 30, 2025 | -0.87% |
| June 30, 2025 | 28.57% |
| March 31, 2025 | 45.60% |
| December 31, 2024 | -282.2% |
| September 30, 2024 | 6.25% |
| June 30, 2024 | 9.51% |
| March 31, 2024 | 16.14% |
| December 31, 2023 | -247.5% |
| September 30, 2023 | 71.37% |
| June 30, 2023 | |
| March 31, 2023 | 94.12% |
| December 31, 2022 | 42.75% |
| September 30, 2022 | |
| June 30, 2022 | |
| March 31, 2022 | |
| September 30, 2015 | -207.4% |
| Date | Value |
|---|---|
| June 30, 2015 | -108.1% |
| March 31, 2015 | -109.3% |
| December 31, 2014 | -1.28K% |
| September 30, 2014 | |
| June 30, 2014 | |
| March 31, 2014 | |
| December 31, 2008 | |
| September 30, 2008 | |
| June 30, 2008 | |
| March 31, 2008 | |
| December 31, 2007 | -224.3K% |
| September 30, 2007 | -178.5K% |
| June 30, 2007 | -199.2K% |
| March 31, 2007 | -93.20K% |
| December 31, 2006 | -78.95K% |
| September 30, 2006 | -63.68K% |
| June 30, 2006 | -132.2K% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Aibotics, Inc. | -- |
| GeneDx Holdings Corp. | -15.50% |
| Ayujoy Herbals Ltd. | -- |
| Arrowhead Pharmaceuticals, Inc. | -237.8% |
| Oncolytics Biotech, Inc. | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | 0.01% |
| Return on Assets | 0.01% |
| Return on Invested Capital | 0.01% |
| Operating Margin (Quarterly) | 35.61% |
| Return on Net Operating Assets | 0.01% |